TTS 2024 - Program Update

Starting in next week's Tribune Pulse we will be featuring our invited speakers and updates every week!

Under the banner of Inform, Transform, Sustain TTS 2024 will facilitate a holistic and comprehensive exploration of the interconnected aspects of the field of transplantation.

About the themes:

Inform - encompasses updates on research, clinical practices, and technological advancements.
Transform - focuses on innovative techniques, new treatment modalities, and transformative approaches to transplantation.
Sustain - emphasizes long-term outcomes, ethical considerations, sustainability, and global accessibility of transplantation services.

The program offers delegates:

Multidimensional learning experience - Participants will explore scientific, clinical, ethical, social, and economic aspects of transplantation from various perspectives, enabling attendees to gain insights from multiple angles and fostering a broader appreciation of the field's complexities.
Synergy - Transplantation involves numerous stakeholders, including clinicians, researchers, patients, policymakers, industry professionals, media and advocacy groups. The integration of diverse perspectives and expertise will be a unique opportunity for participants facilitating the development of comprehensive strategies and policies to enhance transplantation outcomes globally.
Looking to the future - Participants will be challenged to think critically about the future of transplantation. The Inform theme ensures the dissemination of up-to-date knowledge, while the Transform theme promotes innovation and the exploration of new frontiers. The Sustain theme directs our attention to what long-term success looks like for the field, including ethical considerations, patient outcomes, and resource management. This forward-looking approach will inspire attendees to envision the future of transplantation and work collectively towards its realization.

Visit the website

Click for details

Transplantation Journal Highlights

Transplantation - Social Media Content

Wait Time Advantage for Transplant Candidates with HIV Who Accept Kidneys from Donors with HIV Under the HOPE Act

Kidney transplant (KT) candidates with HIV face higher mortality on the waitlist compared with candidates without HIV. Because the HIV Organ Policy Equity (HOPE) Act has expanded the donor pool to allow donors with HIV (D⁺), it is crucial to understand whether this has impacted transplant rates for this population.

Impact of Deceased-donor Acute Kidney Injury on Kidney Transplantation

Even as record numbers of deceased donors are undergoing organ recovery, the global transplant community continues to struggle with a shortage of donor organs and a high organ discard rate. Acute kidney injury (AKI) occurs in many hospitalized patients, including up to 25% of patients in critical condition. Registry studies have shown a significant increase in nonrecovery or organ discard rates in AKI donors, despite most studies reporting similar clinical outcomes compared with non-AKI donors.

Transplantation Direct - Social Media Content

December 2023 - Volume 9 - Issue 12

Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5–adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients

The immunogenicity elicited by the Omicron BA.4/BA.5–adapted bivalent booster vaccine after solid organ transplantation (SOT) has not been characterized.

Upcoming Webinar Presentation

click here for details and to register (must be logged in to view)

Please note: this presentation is for IPTA and TTS Members only

Women in Transplantation 2024 Research Grants

WIT is delighted to announce that requests for applications are now open for the 2024-2026 Research Fellowship Grants for Research in Gender and Sex in Transplantation.

This will be the fourth year that we are offering research fellowships in sex and gender in solid organ transplantation. These fellowships will support the next generation of scientists, furthering our understanding of the importance of sex and gender in transplantation. This is a growing field of interest and the more we learn the closer we are to applying these findings to clinical care to benefit patients and donors.

Visit the Women in Transplantation Website for Complete Details

Latest Recordings

click here to view recording

click here to view recordings (TTS / TID Members)

Member and Section Spotlight

USA - The National Academy of Inventors announced the election of Haval Shirwan to the rank of NAI Fellow.

Havel Shirwan (TTS/IPITA Member) worked with Esma Yolcu to design a molecule that trains the immune system to survey the body for cells that may develop into cancer and eradicate them before cancer takes hold in the body, a transformative finding that provides ground for preventive approaches against cancer. Last year, Shirwan’s team was awarded $3.2 million from the National Institutes of Health to assist in the development of a treatment for Type 1 diabetes that does not require several insulin injections each day.

Read the Article

New - ISODP Educational Watch

Education is the cornerstone of success in improving the outcomes of donation for transplantation. ISODP is committed to enabling sharing of knowledge amongst its membership by providing easy access to an array of learning opportunities in one place.

In this issue will find learning opportunities via links, videos and courses, categorised into the various steps of the donation process, graciously provided by many leading experts and organizations from around the world. The courses referred to in this INDEX are available to the entire international community in two main languages English and/or Spanish. Specific country courses using local official languages are not included in this INDEX.

TTS Call for Nominations

We are now accepting nominations for three (3) Officer positions and nine (9) Councilors-at-large positions representing the Regions.

Click here to see full details

TTS Seeking a New Editor-in-Chief for Transplantation and Transplantation Direct

Jeremy Chapman

Editor-in-Chief
Transplantation Journals

Professor Jeremy R. Chapman, a dedicated leader at the helm of Transplantation and Transplantation Direct, has announced his intention to retire from the role of Editor-in-Chief of The Transplantation Society’s journals at the close of 2024.

Read Full Details

Antibody Mediated Rejection (AMR) Management: Multi-Disciplinary Team (MDT) Conference survey

The care of transplant patients is complex, requiring a collaborative and multi-disciplinary effort to address medical, behavioral, and psychosocial needs.

Despite evidence supporting the benefit of a multidisciplinary approach, very little is known regarding the actual proportion of transplant centers practicing regular, comprehensive, multidisciplinary transplant conferences.

To better understand current practice and the perceived value of multidisciplinary perspectives in the diagnosis and management of transplant patients at risk for immune-mediated injury, transplant professionals worldwide are invited to participate in a brief <10 minute survey.

Click to Access Survey

In the News

China - New rules on organ donation, transplant take effect in May

Dec. 14 - More than a decade after China unveiled its national regulation on human organ transplantation, the first major revision to the rules was released on Dec 14, with the focus on promoting awareness about organ donation and standardizing the management of organ donation, procurement, distribution and transplantation procedures. The revisions also specify legal liabilities for malpractice.

Many would-be kidney donors are ineligible because of their weight or smoking habits: A project helps them qualify

Dec. 10 - Most donation centers require donors to have a BMI lower than 35. They also must not have smoked for at least 90 days before surgery. More permanent factors such as diabetes, cancer, high blood pressure or serious mental health conditions also make potential donors ineligible.

Improvements in Stem Cell Transplants for AML With CRISPR

Dec. 9 - Guenther Koehne, MD, PhD, discusses findings from a phase 1/2 trial. The study is a first-in-human phase 1/2 open-label multicenter trial to establish the safety of trem-cel, a CRISPR/Cas9 gene-edited allograft lacking CD33, as a donor allograft for CD33-positive patients with acute myeloid leukemia at high risk of relapse.

The FDA just approved the first CRISPR gene-editing drug in the U.S.

Dec. 8 - The U.S. Food and Drug Administration (FDA) approved a pair of gene therapies for the painful and potentially fatal blood disorder, sickle cell disease (SCD)–including the first-ever CRISPR gene-editing treatment. It’s a historic moment for the biotechnologies, especially for CRISPR gene-editing, the technology that led to scientists Jennifer Doudna and Emmanuelle Charpentier winning the 2020 Nobel Prize in Chemistry as founders of the technique.

Post-Transplant Fibrosis Monitoring Unnecessary With SVR Prior to Liver Transplant

Dec. 9 - Patients with hepatitis C virus (HCV) who achieve a sustained virologic response have better outcomes after liver transplant and do not require post-transplant fibrosis monitoring.

Transplant recipients push back on CMS testing rule changes

Dec. 6 - New rules from CMS are affecting access to molecular diagnostic testing — a blood test a patient who has received an organ transplant can use at home to track how their body is adjusting to the new organ. The test can provide early signals if the body begins to reject the transplant, at which point physicians can take a biopsy and then decide how to proceed.

Kidney Transplantation Evaluation and Referral in People with Lupus Nephritis-Related End-Stage Kidney Disease

Dec. 7 - End-stage kidney disease (ESKD) or kidney failure, occurs when the kidneys function below 10% percent of their normal ability, meaning that they are not functioning as they should, or they are not functioning at all. Once people reach ESKD, there are only two primary treatment options – dialysis and kidney transplantation. A new study examined access to early steps in the kidney transplantation process in people with lupus nephritis-related end-stage kidney disease (LN-ESKD).

Upcoming Meetings and Announcements

TTS 2024

September 22-25, 2024
Istanbul, Turkey

30th International Congress of The Transplantation Society (TTS 2024)

Member Login

TTS 2024 - Program Update

Starting in next week's Tribune Pulse we will be featuring our invited speakers and updates every week!

Transplantation Journal Highlights

Transplantation - Social Media Content

Transplantation Direct - Social Media Content

Upcoming Webinar Presentation

Women in Transplantation 2024 Research Grants

WIT is delighted to announce that requests for applications are now open for the 2024-2026 Research Fellowship Grants for Research in Gender and Sex in Transplantation.

Latest Recordings

Member and Section Spotlight

USA - The National Academy of Inventors announced the election of Haval Shirwan to the rank of NAI Fellow.

New - ISODP Educational Watch

TTS Call for Nominations

We are now accepting nominations for three (3) Officer positions and nine (9) Councilors-at-large positions representing the Regions.

TTS Seeking a New Editor-in-Chief for Transplantation and Transplantation Direct

Jeremy Chapman

Antibody Mediated Rejection (AMR) Management: Multi-Disciplinary Team (MDT) Conference survey

In the News

China - New rules on organ donation, transplant take effect in May

Many would-be kidney donors are ineligible because of their weight or smoking habits: A project helps them qualify

Improvements in Stem Cell Transplants for AML With CRISPR

The FDA just approved the first CRISPR gene-editing drug in the U.S.

Post-Transplant Fibrosis Monitoring Unnecessary With SVR Prior to Liver Transplant

Transplant recipients push back on CMS testing rule changes

Kidney Transplantation Evaluation and Referral in People with Lupus Nephritis-Related End-Stage Kidney Disease

Upcoming Meetings and Announcements

TTS 2024

Social

Contact

Address

Info